These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2867814)

  • 1. Prevention of arginine-vasopressin-induced motor disturbances by a potent vasopressor antagonist.
    Burnard DM; Veale WL; Pittman QJ
    Brain Res; 1986 Jan; 362(1):40-6. PubMed ID: 2867814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central effects of vasopressin and 1-desamino-8-D-arginine vasopressin (DDAVP) on interleukin-1 fever in the rat.
    Naylor AM; Gubitz GJ; Dinarello CA; Veale WL
    Brain Res; 1987 Jan; 401(1):173-7. PubMed ID: 2949799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of renal vasopressin-stimulated adenylate cyclase by a vasopressor and antidiuretic antagonist, [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl)-D-tyrosine, 4-valine]arginine vasopressin.
    Chang P; Kimura K
    Biochem Biophys Res Commun; 1987 Apr; 144(2):770-8. PubMed ID: 3579941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
    Federico P; Veale WL; Pittman QJ
    Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Kolodziejczyk AM; Seto J; Sawyer WH
    J Med Chem; 1981 Jun; 24(6):701-6. PubMed ID: 7252979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin.
    Martínez MC; Vila JM; Aldasoro M; Medina P; Flor B; Lluch S
    Br J Pharmacol; 1994 Oct; 113(2):419-24. PubMed ID: 7834191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brattleboro rats display increased sensitivity to arginine vasopressin-induced motor disturbances.
    Burnard DM; Pittman QJ; Veale WL
    Brain Res; 1985 Sep; 342(2):316-22. PubMed ID: 4041833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [1-deaminopenicillamine,4-valine]-8-D-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine-vasopressin.
    Manning M; Lowbridge J; Stier CT; Haldar J; Sawyer WH
    J Med Chem; 1977 Sep; 20(9):1228-30. PubMed ID: 926126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antagonistic properties of tetra-substituted analog of vasopressin with selective antidiuretic effects].
    Myshliakova NV; Afanas'eva GA; Strazda GM; Papsuevich OS; Klusha NV; Chipens GI
    Biull Eksp Biol Med; 1992 Feb; 113(2):150-2. PubMed ID: 1611060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists.
    Lammek B; Bankowski K; Misicka A; Manning M; Seto J; Sawyer WH
    J Med Chem; 1989 Jan; 32(1):244-7. PubMed ID: 2909737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of aversive stimulus properties of vasopressin.
    Bluthé RM; Dantzer R; Mormède P; Le Moal M
    Psychopharmacology (Berl); 1985; 87(2):238-41. PubMed ID: 3931152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of vasopressin-induced increase in intracellular Na+ in vascular smooth muscle cells.
    Okada K; Ishikawa S; Saito T
    Am J Physiol; 1991 Dec; 261(6 Pt 2):F1007-12. PubMed ID: 1661077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the vasopressin-enhancing effect on memory retrieval and relearning by a vasopressin V1 receptor antagonist in mice.
    Alescio-Lautier B; Rao H; Paban V; Devigne C; Soumireu-Mourat B
    Eur J Pharmacol; 1995 Dec; 294(2-3):763-70. PubMed ID: 8750743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide.
    García-Villalón AL; Garcia JL; Fernández N; Monge L; Gómez B; Diéguez G
    Br J Pharmacol; 1996 Aug; 118(7):1848-54. PubMed ID: 8842453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis.
    Keppens S; de Wulf H
    Biochim Biophys Acta; 1979 Nov; 588(1):63-9. PubMed ID: 227475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.